Cargando…

Asialoglycoprotein receptor targeted delivery of doxorubicin nanoparticles for hepatocellular carcinoma

We report asialoglycoprotein receptor (ASGPR)-targeted doxorubicin hydrochloride (Dox) nanoparticles (NPs) for hepatocellular carcinoma (HCC). Polyethylene sebacate (PES)-Gantrez® AN 119 Dox NPs of average size 220 nm with PDI < 0.62 and ∼20% Dox loading were prepared by modified nanoprecipitatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pranatharthiharan, Sandhya, Patel, Mitesh D., Malshe, Vinod C., Pujari, Vaishali, Gorakshakar, Ajit, Madkaikar, Manisha, Ghosh, Kanjaksha, Devarajan, Padma V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8244555/ https://www.ncbi.nlm.nih.gov/pubmed/28155331 http://dx.doi.org/10.1080/10717544.2016.1225856

Ejemplares similares

Evaluation of pullulan-functionalized doxorubicin nanoparticles for asialoglycoprotein receptor-mediated uptake in Hep G2 cell line
por: Guhagarkar, Swati A., et al.
Publicado: (2011)

Development of Asialoglycoprotein Receptor-Targeted Nanoparticles for Selective Delivery of Gemcitabine to Hepatocellular Carcinoma
por: Nair, Anroop B., et al.
Publicado: (2019)

Genetics of autism and mental retardation: A spoonful from the sea!
por: Ghosh, Kanjaksha, et al.
Publicado: (2009)

Integration of modern genetic knowledge and technology into public health in India
por: Ghosh, Kanjaksha, et al.
Publicado: (2010)

Quantitation of HBV DNA; another modification of the test: Will it withstand the test of time?
por: Ghosh, Kanjaksha, et al.
Publicado: (2011)

Ernest Beutler (1928-2008)
por: Ghosh, Kanjaksha, et al.
Publicado: (2009)

Use of lectins in immunohematology
por: Gorakshakar, Ajit C., et al.
Publicado: (2016)

Evolution of technology for molecular genotyping in blood group systems
por: Gorakshakar, Ajit, et al.
Publicado: (2017)

Development of asialoglycoprotein receptor directed nanoparticles for selective delivery of curcumin derivative to hepatocellular carcinoma
por: Yousef, Shaimaa, et al.
Publicado: (2018)

Asialoglycoprotein receptor-magnetic dual targeting nanoparticles for delivery of RASSF1A to hepatocellular carcinoma
por: Xue, Wan-Jiang, et al.
Publicado: (2016)

Phenotyping and Genotyping of HNA: Prevalence, Risk of Alloimmunization, and HNA Incompatibilities in Indians
por: Gogri, Harita, et al.
Publicado: (2022)

Evaluation of Danazol, Cyclosporine, and Prednisolone as Single Agent or in Combination for Paroxysmal Nocturnal Hemoglobinuria
por: Ghosh, Kanjaksha, et al.
Publicado: (2013)

Heterogeneity of O blood group in India: Peeping through the window of molecular biology
por: Gogri, Harita, et al.
Publicado: (2018)

Deletion of ABL/BCR on der(9) associated with severe basophilia
por: Vaidya, Shantashri, et al.
Publicado: (2011)

Lactosaminated mesoporous silica nanoparticles for asialoglycoprotein receptor targeted anticancer drug delivery
por: Quan, Guilan, et al.
Publicado: (2015)

Asialoglycoprotein Receptor-Targeted Superparamagnetic Perfluorooctylbromide Nanoparticles
por: Li, Yang, et al.
Publicado: (2021)

Erratum to: Lactosaminated mesoporous silica nanoparticles for asialoglycoprotein receptor targeted anticancer drug delivery
por: Quan, Guilan, et al.
Publicado: (2015)

The asialoglycoprotein receptor in human hepatocellular carcinomas: its expression on proliferating cells
por: Trerè, D, et al.
Publicado: (1999)

Molecular genotyping of ABO blood groups in some population groups from India
por: Ray, Sabita, et al.
Publicado: (2014)

FLT3 and NPM-1 mutations in a cohort of acute promyelocytic leukemia patients from India
por: Swaminathan, Suchitra, et al.
Publicado: (2014)

A Drug Delivery Strategy: Binding Enkephalin to Asialoglycoprotein Receptor by Enzymatic Galactosylation
por: Christie, Michelle P., et al.
Publicado: (2014)

Clinical, hematologic and molecular variability of sickle cell-β thalassemia in western India
por: Mukherjee, Malay B., et al.
Publicado: (2010)

In vitro and in vivo evaluation of self-assembled chitosan nanoparticles selectively overcoming hepatocellular carcinoma via asialoglycoprotein receptor
por: Sun, Rensong, et al.
Publicado: (2021)

Triantennary GalNAc-Functionalized Multi-Responsive Mesoporous Silica Nanoparticles for Drug Delivery Targeted at Asialoglycoprotein Receptor
por: Cordeiro, Rosemeyre, et al.
Publicado: (2022)

Dr. Bhatia's legacy in the development of immunohematology research in the country
por: Ghosh, K., et al.
Publicado: (2014)

Innumerable studies on single nucleotide polymorphisms: What could be its utility?
por: Ghosh, K, et al.
Publicado: (2013)

Monensin inhibits intracellular dissociation of asialoglycoproteins from their receptor
Publicado: (1983)

Distribution of an asialoglycoprotein receptor on rat hepatocyte cell surface
Publicado: (1982)

Immunocytochemical localization of the receptor for asialoglycoprotein in rat liver cells
Publicado: (1982)

LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation
por: Ahn, Green, et al.
Publicado: (2021)

Recycling of the asialoglycoprotein receptor and the effect of lysosomotropic amines in hepatoma cells
Publicado: (1984)

Galactose-modified selenium nanoparticles for targeted delivery of doxorubicin to hepatocellular carcinoma
por: Xia, Yu, et al.
Publicado: (2019)

Molecular organization of ‘Rh’ gene is likely to be heterogeneous across the world
por: Gorakshakar, Ajit C., et al.
Publicado: (2013)

Ligand- and weak base-induced redistribution of asialoglycoprotein receptors in hepatoma cells
Publicado: (1987)

Three-Dimensional Models of the Oligomeric Human Asialoglycoprotein Receptor (ASGP-R)
por: Massarelli, Ilaria, et al.
Publicado: (2010)

Asialoglycoprotein receptor (ASGPR): a peculiar target of liver-specific autoimmunity
por: Roggenbuck, Dirk, et al.
Publicado: (2012)

Delivery of GalNAc-Conjugated Splice-Switching ASOs to Non-hepatic Cells through Ectopic Expression of Asialoglycoprotein Receptor
por: Scharner, Juergen, et al.
Publicado: (2019)

Lactosylated liposomes for targeted delivery of doxorubicin to hepatocellular carcinoma
por: Zhou, Xiaoju, et al.
Publicado: (2012)

Two pathways for the degradation of the H2 subunit of the asialoglycoprotein receptor in the endoplasmic reticulum
Publicado: (1993)

Doxorubicin and resveratrol co-delivery nanoparticle to overcome doxorubicin resistance
por: Zhao, Yuan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_o6dg2fhf4t5i1cdkptagh0erpa